Evenity (Romosozumab 105 mg / 1.17 ml) by UCB.
Indications: Severe osteoporosis in post-menopausal women at high risk of fracture.
Administration: Subcutaneous: 210 mg (2 injections) once monthly for 12 months.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | UCB / Amgen |
| Active ingredient | Romosozumab 105 mg / 1.17 ml — anti-sclerostin monoclonal antibody. |
| Strength & pack | 2 pre-filled pens/syringes (one monthly dose = 210 mg). |
| Form | Solution for injection |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |